Open

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Federal funding opportunity PAR-27-069 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes March 1, 2027

Posted: May 19, 2026
Closes: March 1, 2027
Cost sharing: No
Instrument: Other
Assistance listing: 93.368
Category: Health
Archives: April 30, 2027

Program funding history

Awards made under Assistance Listing 93.368 across FY2025–FY2027, from public federal spending records.

FY2025 obligated: −$6,773
FY2026 obligated: −$5.2M
FY2027 (to date) obligated: $0
Awards in window: 32

No net new obligations were recorded under this listing in the window shown: downward adjustments to earlier awards offset or exceeded new awards in every year. Awards in window counts awards with at least one recorded transaction in the window, adjustments included.

Top recipients: University of Pittsburgh - of the Commonwealth System of Higher Education, Vanderbilt University Medical Center, Icahn School of Medicine at Mount Sinai, Regents of the University of California, San Francisco, the, Research Foundation of the City University of New York

Source: USAspending.gov · refreshed October 2026

Synopsis

The purpose of this Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR) is to solicit applications to access stored blood plasma, blood serum, and extracted DNA from the All of Us Research Program supported Biobank to advance the program's mission of accelerating health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us. All of Us partnered research studies are collaborative initiatives funded by a study sponsor external to All of Us to collect and add new data to the All of Us Researcher Workbench in accordance with All of Us" best practices. All of Us partnered research studies are open to the broad scientific community and require investigators to apply for and receive an X01 award under this announcement. This will enable longitudinal follow‐up and repeat sampling, and provide multiomic data (genomics, proteomics, metabolomics, and other high‐dimensional molecular profiles), integrated clinical, environmental, and life‐course data, infrastructure designed to support future clinical‐trial recruitment, and public‐private partnership pathways. This opportunity will enable researchers to conduct assays to evaluate associations between newly collected and existing All of Us data and add new data to the All of Us dataset for broad use by the research community. High-priority areas for biospecimen analyses may include, but are not limited to, large scale projects that propose integrated multiomics analyses, early disease detection, biomarker discovery or validation, novel risk models for incident disease, and/or novel disease stratification for chronic disease risk, diagnosis, and prognosis, in support of advancing precision medicine. For more information, please visit the All of Us X01 Partnered Research Studies Resource webpage.

Who can apply

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Private institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
State governments
County governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/Foreign Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source — applying is free.

View on Grants.gov

Agency contact: National Institutes of Health · [email protected] · 301-402-2541

New to federal funding? How to read an announcement · Who can apply · How grants work

Remind me before this closes

One email about a week before this grant closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.

Stored once per grant, used only for this watch’s emails; every one carries a one-click unsubscribe. Privacy

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.

No spam, ever. Privacy

Similar grants

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
RFA-AI-28-024 · National Institutes of Health · closes February 11, 2027
Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)
PAR-28-062 · National Institutes of Health · closes January 25, 2027
Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
PAR-27-071 · National Institutes of Health · closes January 11, 2027
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
PAR-25-020 · National Institutes of Health · closes September 29, 2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
PAR-25-248 · National Institutes of Health · closes October 8, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
RFA-DA-26-055 · National Institutes of Health · closes December 3, 2027

Same-day alerts, matched to you

The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.

Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.

See pricing